Defective sarcolemmal phospholipase C signaling in diabetic cardiomyopathy

Molecular and Cellular Biochemistry

Volumn 261, Issue 1, 2004, Pages 193-199

  Tappia, Paramjit S ^a,b   Asemu, Girma ^a,b   Aroutiounova, Nina ^a,b   Dhalla, Naranjan S ^a,b  

^a ST BONIFACE GENERAL HOSPITAL   (Canada)

^b UNIVERSITY OF MANITOBA   (Canada)

Author keywords

Diabetic cardiomyopathy; Phospholipase C; Phospholipid mediated signaling; Sarcolemma

Indexed keywords

PHOSPHOLIPASE C; STREPTOZOCIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIOMYOPATHY; CELL ISOLATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE MODEL; ENZYME ACTIVITY; FROZEN SECTION; HEART FUNCTION; HEART LEFT VENTRICLE; HEART MUSCLE CONTRACTILITY; HEART MUSCLE FIBER MEMBRANE; IMMUNOFLUORESCENCE; MALE; NONHUMAN; PROTEIN LOCALIZATION; RAT; SIGNAL TRANSDUCTION; TISSUE DISTRIBUTION;

ANIMALS; CARDIOMYOPATHIES; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC ANGIOPATHIES; GTP-BINDING PROTEIN ALPHA SUBUNITS, GQ-G11; HEART VENTRICLES; INOSITOL 1,4,5-TRISPHOSPHATE; INSULIN; ISOENZYMES; MALE; MYOCYTES, CARDIAC; PHOSPHOLIPASE C; RATS; SARCOLEMMA;

ANIMALIA;

EID: 3442892085     PISSN: 03008177     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:MCBI.0000028756.31782.46     Document Type: Article

References (44)

1. James SR, Downes CP: Structural and mechanistic features of phospholipase C: Effectors of inositol phospholipid-mediated signal transduction. Cell Signal 9: 329-336, 1997
2. Katan M: Families of phosphoinositie-specific phospholipase C: Structure and function. Biochim Biophys Acta 1436: 5-17, 1998
3. D'Santos CS, Clarke JH, Divecha N: Phospholipid signaling in the nucleus. Biochim Biophys Acta 1436: 201-232, 1998
4. Rebecchi MJ, Pentyala SN: Structure, function, and control of phosphoinositide-specific phospholipase C. Physiol Rev 80: 1291-1335, 2000
5. Rhee SG: Regulation of phosphoinositide-specific phospholipase C. Annu Rev Biochem 70: 281-312, 2001
6. 3 binding site in rat heart sarcoplasmic reticulum. J Mol Cell Cardiol 26: 341-349, 1994
7. Gilbert JC, Shirayama T, Pappano AJ: Inositol trisphosphate promotes Na-Ca exchange current by releasing calcium from sarcoplasmic reticulum in cardiac myocytes. Circ Res 69: 1632-1639, 1991
8. Puceat M, Vassort G: Signaling by protein kinase C isoforms in the heart. Mol Cell Biochem 157: 65-72, 1996
9. Kamp TJ, Hell JW: Regulation of cardiac L-type calcium channels by protein kinase A and protein kinase C. Circ Res 87: 1095-1102, 2000
10. Ahmed SS, Jaferi GA, Narang RM, Regan T: Preclinical abnormality of left ventricular function in diabetes mellitus. Am Heart J 80: 153-158, 1975
11. Rubler S, Sajadi RM, Araoye MA, Holford FD: Noninvasive estimation of myocardial performance in patients with diabetes: Effect of alcohol administration. Diabetes 27: 127-134, 1978
12. Kannel WB, Hjortland M, Castelli WP: Role of diabetes in congestive heart failure: The Framingham study. Am J Cardiol 34: 29-34, 1974
13. Heyliger CE, Pierce GN, Singal PK, Beamish RE, Dhalla NS: Cardiac alpha- and beta-adrenergic receptor alterations in diabetic cardiomyopathy. Basic Res Cardiol 77: 610-618, 1982
14. 1-adrenoceptor and its signal transduction in streptozotocin-induced diabetic rats. Am J Physiol 263: E425-E429, 1992
15. 1-adrenoceptor signaling system in diabetic rats. Eur J Pharmacol 244: 105-109, 1993
16. Fein FS, Sonnenblick EH: Diabetic cardiomyopathy. Prog Cardiovasc Dis 27: 255-270, 1985
17. Regan TJ, Ettinger PO, Khan MI, Jesrani MV, Lyons MM, Oldewurtel HA, Weber M: Altered myocardial function and metabolism in chronic diabetes mellitus without ischemia in dogs. Circ Res 35: 222-237, 1974
18. Williams SA, Tappia PS, Yu CH, Bibeau M, Panagia V, Weber M: Impairment of the sarcolemmal phospholipase D-phosphatidate phosphohydrolase pathway in diabetic cardiomyopathy. J Mol Cell Cardiol 30: 109-118, 1998
19. Panagia V, Taira Y, Ganguly PK, Tung S, Dhalla NS: Alterations in phospholipid N-methylation of cardiac subcellular membranes due to experimentally induced diabetes in rats. J Clin Invest 86: 777-784, 1990
20. 2+-cycling proteins may underlie sarcoplasmic reticulum dysfunction in the diabetic heart. Diabetes 50: 2133-2138, 2001
21. Vecchini A, Del Rosso F, Binaglia L, Dhalla NS, Panagia V: Molecular defects in sarcolemmal glycerophospholipid subclasses in diabetic cardiomyopathy. J Mol Cell Cardiol 32: 1061-1074, 2000
22. Tappia PS, Liu SY, Shatadal S, Takeda N, Dhalla NS, Panagia V: Changes in sarcolemmal PLC isoenzymes in postinfarct congestive heart failure: Partial correction by imidapril. Am J Physiol 277: H40-H49, 1999
23. Ju H, Zhao S, Jassal D, Dixon IMC: Effect of AT1 receptor blockade on cardiac collagen remodelling after myocardial infarction. Cardiovasc Res 35: 223-232, 1997
24. Tappia PS, Padua RR, Panagia V, Kardami E: Fibroblast growth factor-2 stimulates phospholipase Cβ in adult cardiomyocytes. Biochem Cell Biol 77: 569-575, 1999
25. 2+ and cardiac force. Am J Physiol 271: H651-H659, 1996
26. 2+ to phosphatidic acid in diabetic rats. Can J Physiol 12: 1092-1098, 1996
27. 2+-binding and positive inotropy in rat heart. Am J Physiol 247: H880-H885, 1984
28. Langer GA, Rich TL: Phospholipase D produces increased contractile force in rabbit ventricular muscle. Circ Res 56: 146-149, 1985
29. Kurz T, Wolf RA, Corr PB: Phosphatidic acid stimulates inositol 1,4,5-trisphosphate production in adult cardiac myocytes. Circ Res 72: 701-706, 1993
30. Ganguly PK, Beamish RE, Dhalla KS, Innes IR, Dhalla NS: Norepinephrine storage, distribution, and release in diabetic cardiomyopathy. Am J Physiol 252: E734-E739, 1987
31. 1-adrenoceptor-mediated phosphoinositide breakdown and inotropic responses in diabetic hearts. Am J Physiol 260: H557-H562, 1991
32. Sethi R, Elimban V, Chapman D, Dixon IM, Dhalla NS: Differential alterations in left and right ventricular G-proteins in congestive heart failure due to myocardial infarction. J Mol Cell Cardiol 30: 2153-2163, 1998
33. Yang JM, Cho CM, Kong KA, Jang IS, Kim HW, Juhnn YS: Increased expression of Gαq protein in the heart of streptozotocin-induced diabetic rats. Exp Mol Med 31: 179-184, 1999
34. 1-adrenoceptor stimulation in isolated working hearts from diabetic rats. J Cardiovasc Pharmacol 20: 559-562, 1992
35. 2+ current in diabetic rat cardiomyocytes. Am J Physiol 274: H1849-H1857, 1998
36. 2+ and adrenergic responsiveness of cardiac myocytes in streptozotocin-induced diabetes. Clin Exp Pharmacol Physiol 26: 347-353, 1999
37. 1 is hypoactive but hyperresponsive to phosphatidic acid in diabetic cardiomyopathy. J Mol Cell Cardiol 30: A257, 1998
38. 1 signaling in diabetic cardiomyopathy. J Mol Cell Cardiol 32: A46, 2000
39. Dhalla NS, Liu X, Panagia V, Takeda N: Subcellular remodeling and heart dysfunction in chronic diabetes. Cardiovasc Res 40: 239-247, 1998
40. Meij JTA, Suzuki S, Panagia V, Dhalla NS: Oxidative stress modifies the activity of cardiac sarcolemmal phospholipase C. Biochim Biophys Acta 1199: 6-12, 1994
41. Tappia PS, Liu S-Y, Tong Y, Ssenyange S, Panagia V: Reduction of phosphatidylinositol 4,5-bisphosphate mass in heart sarcolemma during diabetic cardiomyopathy. Adv Exp Med Biol 498: 183-190, 2001
42. 2+ pump activity during diabetes mellitus. Am J Physiol 252: H540-H544, 1987
43. i responses to isoproterenol and camp in isolated cardiomyocytes from experimental diabetic rats. Am J Physiol 266: H2334-H2342, 1994
44. 2+-ATPase expression in streptozotocin-induced diabetic rat. Biochem Biophys Res Commun 203: 113-120, 1994